Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive protein

Alessandro Sciahbasi1, Felicita Andreotti, Raimondo De Cristofaro

  • 1Institute of Cardiology, Catholic University, Rome, Italy.

Insights

High C-reactive protein (CRP) levels before coronary angioplasty predict increased von Willebrand factor (vWF) and platelet reactivity in unstable angina patients. These inflammatory markers may explain worse outcomes in unstable patients.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Hemostasis and Thrombosis

Background:

  • C-reactive protein (CRP) is linked to coronary thrombosis risk.
  • Mechanisms connecting inflammation and hemostasis in coronary angioplasty require elucidation.

Purpose of the Study:

  • Investigate the relationship between inflammatory state and hemostatic response post-coronary angioplasty.
  • Determine if preprocedural C-reactive protein levels predict changes in hemostatic markers.

Main Methods:

  • Measured plasma levels of vWF antigen, vWF collagen binding activity, vWF-cleaving-protease, CRP, and platelet reactivity before and after angioplasty.
  • Stratified 35 patients (18 unstable, 17 stable angina) by preprocedural CRP levels (<3 mg/l vs. >=3 mg/l).

Main Results:

  • Patients with unstable angina and high preprocedural CRP showed significant increases in vWF antigen, vWF collagen-binding, CRP, and platelet reactivity post-angioplasty.
  • Changes in vWF antigen and vWF collagen-binding correlated with CRP level changes post-angioplasty.
  • No significant changes observed in the stable angina group or unstable angina patients with low CRP.

Conclusions:

  • High preprocedural CRP levels predict a significant increase in vWF after angioplasty in unstable angina patients.
  • The rise in vWF is associated with elevated CRP and enhanced platelet reactivity.
  • These inflammatory and hemostatic changes may contribute to the poorer prognosis in unstable angina patients with elevated inflammation markers.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...